Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 11 (2011), Pages 2071-2090
http://dx.doi.org/10.1100/2011/873895
Review Article

Overlapping, Additive and Counterregulatory Effects of Type II and I Interferons on Myeloid Dendritic Cell Functions

Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy

Received 8 April 2011; Accepted 27 September 2011

Academic Editor: Fulvio D'Acquisto

Copyright © 2011 Loredana Frasca and Roberto Lande. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. K. Chelbi-Alix and J. Wietzerbin, “Interferon, a growing cytokine family: 50 years of interferon research,” Biochimie, vol. 89, no. 6-7, pp. 713–718, 2007. View at Publisher · View at Google Scholar · View at PubMed
  2. E. M. Coccia, “IFN regulation and functions in myeloid dendritic cells,” Cytokine and Growth Factor Reviews, vol. 19, no. 1, pp. 21–32, 2008. View at Publisher · View at Google Scholar · View at PubMed
  3. C. A. Bonjardim, P. C. P. Ferreira, and E. G. Kroon, “Interferons: signaling, antiviral and viral evasion,” Immunology Letters, vol. 122, no. 1, pp. 1–11, 2009. View at Publisher · View at Google Scholar · View at PubMed
  4. O. H. Krämer and T. Heinzel, “Phosphorylation-acetylation switch in the regulation of STAT1 signaling,” Molecular and Cellular Endocrinology, vol. 315, no. 1-2, pp. 40–48, 2009. View at Publisher · View at Google Scholar · View at PubMed
  5. X. Hu and L. B. Ivashkiv, “Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases,” Immunity, vol. 31, no. 4, pp. 539–550, 2009. View at Publisher · View at Google Scholar · View at PubMed
  6. K. Schroder, M. J. Sweet, and D. A. Hume, “Signal integration between IFNγ and TLR signalling pathways in macrophages,” Immunobiology, vol. 211, no. 6–8, pp. 511–524, 2006. View at Publisher · View at Google Scholar · View at PubMed
  7. L. C. Platanias, “Mechanisms of type-I- and type-II-interferon-mediated signalling,” Nature Reviews Immunology, vol. 5, no. 5, pp. 375–386, 2005. View at Publisher · View at Google Scholar · View at PubMed
  8. A. Billiau and P. Matthys, “Interferon-γ: a historical perspective,” Cytokine and Growth Factor Reviews, vol. 20, no. 2, pp. 97–113, 2009. View at Publisher · View at Google Scholar · View at PubMed
  9. R. Reljic, “IFN-γ therapy of tuberculosis and related infections,” Journal of Interferon and Cytokine Research, vol. 27, no. 5, pp. 353–364, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. J. Zhang, “Yin and yang interplay of IFN-γ in inflammation and autoimmune disease,” Journal of Clinical Investigation, vol. 117, no. 4, pp. 871–873, 2007. View at Publisher · View at Google Scholar · View at PubMed
  11. H. Kelchtermans, A. Billiau, and P. Matthys, “How interferon-γ keeps autoimmune diseases in check,” Trends in Immunology, vol. 29, no. 10, pp. 479–486, 2008. View at Publisher · View at Google Scholar · View at PubMed
  12. L. Flaishon, R. Hershkoviz, F. Lantner et al., “Autocrine secretion of interferon γ negatively regulates homing of immature B cells,” Journal of Experimental Medicine, vol. 192, no. 9, pp. 1381–1387, 2000. View at Publisher · View at Google Scholar
  13. Y. Refaeli, L. Van Parijs, S. I. Alexander, and A. K. Abbas, “Interferon γ is required for activation-induced death of T lymphocytes,” Journal of Experimental Medicine, vol. 196, no. 7, pp. 999–1005, 2002. View at Publisher · View at Google Scholar
  14. Z. Wang, J. Hong, W. Sun et al., “Role of IFN-γ in induction of Foxp3 and conversion of CD4+CD25 T cells to CD4+ Tregs,” Journal of Clinical Investigation, vol. 116, no. 9, pp. 2434–2441, 2006. View at Publisher · View at Google Scholar · View at PubMed
  15. L. E. Harrington, R. D. Hatton, P. R. Mangan et al., “Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages,” Nature Immunology, vol. 6, no. 11, pp. 1123–1132, 2005. View at Publisher · View at Google Scholar · View at PubMed
  16. E. Bettelli, M. Oukka, and V. K. Kuchroo, “TH-17 cells in the circle of immunity and autoimmunity,” Nature Immunology, vol. 8, no. 4, pp. 345–350, 2007. View at Publisher · View at Google Scholar · View at PubMed
  17. L. Frasca, M. Nasso, F. Spensieri et al., “IFN-γ arms human dendritic cells to perform multiple effector functions,” Journal of Immunology, vol. 180, no. 3, pp. 1471–1481, 2008. View at Google Scholar
  18. A. N. Theofilopoulos, R. Baccala, B. Beutler, and D. H. Kono, “Type I interferons (α/β) in immunity and autoimmunity,” Annual Review of Immunology, vol. 23, pp. 307–336, 2005. View at Publisher · View at Google Scholar · View at PubMed
  19. M. Prinz and U. Kalinke, “New lessons about old molecules: how type I interferons shape Th1/Th17-mediated autoimmunity in the CNS,” Trends in Molecular Medicine, vol. 16, no. 8, pp. 379–386, 2010. View at Publisher · View at Google Scholar · View at PubMed
  20. G. Trinchieri, “Type I interferon: friend or foe?” Journal of Experimental Medicine, vol. 207, no. 10, pp. 2053–2063, 2010. View at Publisher · View at Google Scholar · View at PubMed
  21. G. M. Keating, “Peginterferon-α-2a (40kD): a review of its use in chronic hepatitis B,” Drugs, vol. 69, no. 18, pp. 2633–2660, 2009. View at Publisher · View at Google Scholar · View at PubMed
  22. S. Zhao, E. Liu, P. Chen et al., “A comparison of peginterferon α-2a and α-2b for treatment-naive patients with chronic hepatitis C virus: a meta-analysis of randomized trials,” Clinical Therapeutics, vol. 32, no. 9, pp. 1565–1577, 2010. View at Publisher · View at Google Scholar · View at PubMed
  23. P. Rizza, F. Moretti, and F. Belardelli, “Recent advances on the immunomodulatory effects of IFN-α: implications for cancer immunotherapy and autoimmunity,” Autoimmunity, vol. 43, no. 3, pp. 204–209, 2010. View at Publisher · View at Google Scholar · View at PubMed
  24. P. Kalinski and H. Okada, “Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors,” Seminars in Immunology, vol. 22, no. 3, pp. 173–182, 2010. View at Publisher · View at Google Scholar · View at PubMed
  25. P. Kalinski, “Dendritic cells in immunotherapy of established cancer: roles of signals 1, 2, 3 and 4,” Current Opinion in Investigational Drugs, vol. 10, no. 6, pp. 526–535, 2009. View at Google Scholar
  26. A. Snijders, P. Kalinski, C. M. U. Hilkens, and M. L. Kapsenberg, “High-level IL-12 production by human dendritic cells requires two signals,” International Immunology, vol. 10, no. 11, pp. 1593–1598, 1998. View at Publisher · View at Google Scholar
  27. P. J. Mosca, A. C. Hobeika, T. M. Clay et al., “A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-γ treatment,” Blood, vol. 96, no. 10, pp. 3499–3504, 2000. View at Google Scholar
  28. M. E. Remoli, V. Gafa, E. Giacomini, M. Severa, R. Lande, and E. M. Coccia, “IFN-β modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression,” European Journal of Immunology, vol. 37, no. 12, pp. 3499–3508, 2007. View at Publisher · View at Google Scholar · View at PubMed
  29. T. Nagai, O. Devergne, T. F. Mueller, D. L. Perkins, J. M. Van Seventer, and G. A. Van Seventer, “Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation,” Journal of Immunology, vol. 171, no. 10, pp. 5233–5243, 2003. View at Google Scholar
  30. E. Giacomini, M. E. Remoli, V. Gafa, M. Pardini, L. Fattorini, and E. M. Coccia, “IFN-β improves BCG immunogenicity by acting on DC maturation,” Journal of Leukocyte Biology, vol. 85, no. 3, pp. 462–468, 2009. View at Publisher · View at Google Scholar · View at PubMed
  31. V. Gafa, M. E. Remoli, E. Giacomini, M. Severa, R. Grillot, and E. M. Coccia, “Enhancement of anti-aspergillus T helper type 1 response by interferon-β-conditioned dendritic cells,” Immunology, vol. 131, no. 2, pp. 282–288, 2010. View at Publisher · View at Google Scholar · View at PubMed
  32. T. Luft, P. Luetjens, H. Hochrein et al., “IFN-α enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells,” International Immunology, vol. 14, no. 4, pp. 367–380, 2002. View at Google Scholar
  33. R. Lemoine, F. Velge-Roussel, F. Herr et al., “Interferon gamma licensing of human dendritic cells in T-helper-independent CD8+ alloimmunity,” Blood, vol. 116, no. 16, pp. 3089–3098, 2010. View at Publisher · View at Google Scholar · View at PubMed
  34. J. H. Yen, W. Kong, and D. Ganea, “IFN-β inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9,” Journal of Immunology, vol. 184, no. 7, pp. 3478–3486, 2010. View at Publisher · View at Google Scholar · View at PubMed
  35. P. L. Vieira, E. C. de Jong, E. A. Wierenga, M. L. Kapsenberg, and P. Kaliński, “Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction,” Journal of Immunology, vol. 164, no. 9, pp. 4507–4512, 2000. View at Google Scholar
  36. S. Parlato, S. M. Santini, C. Lapenta et al., “Expression of CCR-7, MIP-3β, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities,” Blood, vol. 98, no. 10, pp. 3022–3029, 2001. View at Publisher · View at Google Scholar
  37. R. B. Mailliard, A. Wankowicz-Kalinska, Q. Cai et al., “α-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity,” Cancer Research, vol. 64, no. 17, pp. 5934–5937, 2004. View at Publisher · View at Google Scholar · View at PubMed
  38. G. Fedele, L. Frasca, R. Palazzo, E. Ferrero, F. Malavasi, and C. M. Ausiello, “CD38 is expressed on human mature monocyte-derived dendritic cells and is functionally involved in CD83 expressioin and IL-12 induction,” European Journal of Immunology, vol. 34, no. 5, pp. 1342–1350, 2004. View at Publisher · View at Google Scholar · View at PubMed
  39. L. Frasca, G. Fedele, S. Deaglio et al., “CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells,” Blood, vol. 107, no. 6, pp. 2392–2399, 2006. View at Publisher · View at Google Scholar · View at PubMed
  40. P. Hartiala, J. Hytönen, H. Yrjänäinen et al., “TLR2 utilization of Borrelia does not induce p38- and IFN-β autocrine loop-dependent expression of CD38, resulting in poor migration and weak IL-12 secretion of dendritic cells,” Journal of Immunology, vol. 184, no. 10, pp. 5732–5742, 2010. View at Publisher · View at Google Scholar · View at PubMed
  41. M. C. Lebre, T. Burwell, P. L. Vieira et al., “Differential expression of inflammatory chemokines by Th1- and Th2-cell promoting dendritic cells: a role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation,” Immunology and Cell Biology, vol. 83, no. 5, pp. 525–535, 2005. View at Publisher · View at Google Scholar · View at PubMed
  42. E. Padovan, G. C. Spagnoli, M. Ferrantini, and M. Heberer, “IFN-α2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells,” Journal of Leukocyte Biology, vol. 71, no. 4, pp. 669–676, 2002. View at Google Scholar
  43. R. Lande, E. Giacomini, T. Grassi et al., “IFN-αβ released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells,” Journal of Immunology, vol. 170, no. 3, pp. 1174–1182, 2003. View at Google Scholar
  44. D. Rojas and R. Krishnan, “IFN-γ generates maturation-arrested dendritic cells that induce T cell hyporesponsiveness independent of Foxp3+ T-regulatory cell generation,” Immunology Letters, vol. 132, no. 1-2, pp. 31–37, 2010. View at Publisher · View at Google Scholar · View at PubMed
  45. A. Eljaafari, Y. P. Li, and P. Miossec, “IFN-γ, as secreted during an alloresponse, induces differentiation of monocytes into tolerogenic dendritic cells, resulting in FoxP3+ regulatory T cell promotion,” Journal of Immunology, vol. 183, no. 5, pp. 2932–2945, 2009. View at Publisher · View at Google Scholar · View at PubMed
  46. M. Shinomiya, S. M. Fazle Akbar, H. Shinomiya, and M. Onji, “Transfer of dendritic cells (DC) ex vivo stimulated with interferon- gamma (IFN-γ) down-modulates autoimmune diabetes in non-obese diabetic (nod) mice,” Clinical and Experimental Immunology, vol. 117, no. 1, pp. 38–43, 1999. View at Publisher · View at Google Scholar
  47. S. B. Adikari, H. Lian, H. Link, Y. M. Huang, and B. G. Xiao, “Interferon-γ-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis,” Clinical and Experimental Immunology, vol. 138, no. 2, pp. 230–236, 2004. View at Publisher · View at Google Scholar · View at PubMed
  48. G. J. Freeman, A. J. Long, Y. Iwai et al., “Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation,” Journal of Experimental Medicine, vol. 192, no. 7, pp. 1027–1034, 2000. View at Publisher · View at Google Scholar
  49. B. Schreiner, M. Mitsdoerffer, B. C. Kieseier et al., “Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis,” Journal of Neuroimmunology, vol. 155, no. 1-2, pp. 172–182, 2004. View at Publisher · View at Google Scholar · View at PubMed
  50. G. Murugaiyan, A. Mittal, and H. L. Weiner, “Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-γ limits IL-17-mediated autoimmune inflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 25, pp. 11495–11500, 2010. View at Publisher · View at Google Scholar · View at PubMed
  51. G. Fedele, M. Nasso, F. Spensieri et al., “Lipopolysaccharides from bordetella pertussis and bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th1l7-polarized responses,” Journal of Immunology, vol. 181, no. 1, pp. 208–216, 2008. View at Google Scholar
  52. X. Zhang, J. Jin, Y. Tang, D. Speer, D. Sujkowska, and S. Markovic-Plese, “IFN-β1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation,” Journal of Immunology, vol. 182, no. 6, pp. 3928–3936, 2009. View at Publisher · View at Google Scholar · View at PubMed
  53. X. Zhang and S. Markovic-Plese, “Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis,” Clinical Neurology and Neurosurgery, vol. 112, no. 7, pp. 641–645, 2010. View at Publisher · View at Google Scholar · View at PubMed
  54. M. H. Wenink, K. C. M. Santegoets, J. C. A. Broen et al., “TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop,” Journal of Immunology, vol. 183, no. 11, pp. 6960–6970, 2009. View at Publisher · View at Google Scholar · View at PubMed
  55. B. Guo, E. Y. Chang, and G. Cheng, “The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice,” Journal of Clinical Investigation, vol. 118, no. 5, pp. 1680–1690, 2008. View at Publisher · View at Google Scholar · View at PubMed
  56. M. L. Shinohara, J. H. Kim, V. A. Garcia, and H. Cantor, “Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin,” Immunity, vol. 29, no. 1, pp. 68–78, 2008. View at Publisher · View at Google Scholar · View at PubMed
  57. A. Takaoka, Y. Mitani, H. Suemori et al., “Cross talk between interferon-γ and -α/β signaling components in caveolar membrane domains,” Science, vol. 288, no. 5475, pp. 2357–2360, 2000. View at Publisher · View at Google Scholar
  58. D. J. Gough, N. L. Messina, L. Hii et al., “Functional crosstalk between type I and II interferon through the regulated expression of STAT1,” PLoS Biology, vol. 8, no. 4, 2010. View at Publisher · View at Google Scholar · View at PubMed
  59. F. Zhou, “Molecular mechanisms of IFN-γ to up-regulate MHC class i antigen processing and presentation,” International Reviews of Immunology, vol. 28, no. 3-4, pp. 239–260, 2009. View at Publisher · View at Google Scholar · View at PubMed
  60. M. Jinushi, T. Takehara, T. Kanto et al., “Critical role of MHC class I-related chain A and B expression on IFN-α-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection,” Journal of Immunology, vol. 170, no. 3, pp. 1249–1256, 2003. View at Google Scholar
  61. A. G. Sikora, N. Jaffarzad, Y. Hailemichael et al., “IFN-α enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity,” Journal of Immunology, vol. 182, no. 12, pp. 7398–7407, 2009. View at Publisher · View at Google Scholar · View at PubMed
  62. J. E. Boudreau, K. B. Stephenson, F. Wang et al., “IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells,” Cancer Research, vol. 71, no. 7, pp. 2497–2506, 2011. View at Publisher · View at Google Scholar · View at PubMed
  63. L. Frasca, S. W. Stonier, W. W. Overwijk, and K. S. Schluns, “Differential mechanisms of memory CD8 T cell maintenance by individual myeloid cell types,” Journal of Leukocyte Biology, vol. 88, no. 1, pp. 69–78, 2010. View at Publisher · View at Google Scholar · View at PubMed
  64. B. Morandi, L. Mortara, P. Carrega et al., “NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs,” International Immunology, vol. 21, no. 5, pp. 599–606, 2009. View at Publisher · View at Google Scholar · View at PubMed
  65. V. Budagian, E. Bulanova, R. Paus, and S. Bulfone-Paus, “IL-15/IL-15 receptor biology: a guided tour through an expanding universe,” Cytokine and Growth Factor Reviews, vol. 17, no. 4, pp. 259–280, 2006. View at Publisher · View at Google Scholar · View at PubMed
  66. S. W. Stonier and K. S. Schluns, “Trans-presentation: a novel mechanism regulating IL-15 delivery and responses,” Immunology Letters, vol. 127, no. 2, pp. 85–92, 2010. View at Publisher · View at Google Scholar · View at PubMed
  67. F. Mattei, G. Schiavoni, F. Belardelli, and D. F. Tough, “IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation,” Journal of Immunology, vol. 167, no. 3, pp. 1179–1187, 2001. View at Google Scholar
  68. M. Jinushi, T. Takehara, T. Tatsumi et al., “Autocrine/Paracrine IL-15 That Is Required for Type I IFN-Mediated Dendritic Cell Expression of MHC Class I-Related Chain A and B Is Impaired in Hepatitis C Virus Infection,” Journal of Immunology, vol. 171, no. 10, pp. 5423–5429, 2003. View at Google Scholar
  69. M. Lucas, W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach, “Dendritic cells prime natural killer cells by trans-presenting interleukin 15,” Immunity, vol. 26, no. 4, pp. 503–517, 2007. View at Publisher · View at Google Scholar · View at PubMed
  70. E. Mortier, T. Woo, R. Advincula, S. Gozalo, and A. Ma, “IL-15Rα chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation,” Journal of Experimental Medicine, vol. 205, no. 5, pp. 1213–1225, 2008. View at Publisher · View at Google Scholar · View at PubMed
  71. K. Arimoto-Miyamoto, N. Kadowaki, T. Kitawaki, S. Iwata, C. Morimoto, and T. Uchiyama, “Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4+ T-cell differentiation,” Immunology, vol. 130, no. 1, pp. 137–149, 2010. View at Publisher · View at Google Scholar · View at PubMed
  72. L. Ma, C. Mauro, G. H. Cornish et al., “Ig gene-like molecule CD31 plays a nonredundant role in the regulation of T-cell immunity and tolerance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 45, pp. 19461–19466, 2010. View at Publisher · View at Google Scholar · View at PubMed
  73. H. C. Heystek, B. den Drijver, M. L. Kapsenberg, R. A. W. van Lier, and E. C. de Jong, “Type I IFNs differentially modulate IL-12p70 production by human dendritic cells depending on the maturation status of the cells and counteract IFN-γ-mediated signaling,” Clinical Immunology, vol. 107, no. 3, pp. 170–177, 2003. View at Publisher · View at Google Scholar
  74. R. Rajaiah, M. Puttabyatappa, S. K. Polumuri, and K. D. Moudgil, “Interleukin-27 and interferon-γ are involved in regulation of autoimmune arthritis,” The Journal of Biological Chemistry, vol. 286, no. 4, pp. 2817–2825, 2011. View at Publisher · View at Google Scholar · View at PubMed
  75. S. L. Masters, L. A. Mielke, A. L. Cornish et al., “Regulation of interleukin-1β by interferon-γ is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production,” EMBO Reports, vol. 11, no. 8, pp. 640–646, 2010. View at Publisher · View at Google Scholar · View at PubMed
  76. A. A. Byrnes, M. Xiaojing, P. Cuomo et al., “Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity,” European Journal of Immunology, vol. 31, no. 7, pp. 2026–2034, 2001. View at Google Scholar
  77. G. Gautier, M. Humbert, F. Deauvieau et al., “A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells,” Journal of Experimental Medicine, vol. 201, no. 9, pp. 1435–1446, 2005. View at Publisher · View at Google Scholar · View at PubMed
  78. P. Kaliński, J. H. N. Schuitemaker, C. M. U. Hilkens, E. A. Wierenga, and M. L. Kapsenberg, “Final maturation of dendritic cells is associated with impaired responsiveness to IFN-γ and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells,” Journal of Immunology, vol. 162, no. 6, pp. 3231–3236, 1999. View at Google Scholar
  79. B. L. McRae, B. A. Beilfuss, and G. A. van Seventer, “IFN-β differentially regulates CD40-induced cytokine secretion by human dendritic cells,” Journal of Immunology, vol. 164, no. 1, pp. 23–28, 2000. View at Google Scholar
  80. B. Pulendran, H. Tang, and T. L. Denning, “Division of labor, plasticity, and crosstalk between dendritic cell subsets,” Current Opinion in Immunology, vol. 20, no. 1, pp. 61–67, 2008. View at Publisher · View at Google Scholar · View at PubMed
  81. R. B. Mailliard, S. Egawa, Q. Cai et al., “Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type responses,” Journal of Experimental Medicine, vol. 195, no. 4, pp. 473–483, 2002. View at Publisher · View at Google Scholar
  82. M. C. Gauzzi, I. Canini, P. Eid, F. Belardelli, and S. Gessani, “Loss of type I IFN receptors and impaired IFN responsiveness during terminal maturation of monocyte-derived human dendritic cells,” Journal of Immunology, vol. 169, no. 6, pp. 3038–3045, 2002. View at Google Scholar
  83. R. J. Belland, D. E. Nelson, D. Virok et al., “Transcriptome analysis of chlamydial growth during IFN-γ-mediated persistence and reactivation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 15971–15976, 2003. View at Publisher · View at Google Scholar · View at PubMed
  84. P. Österlund, V. Veckman, J. Sirén et al., “Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells,” Journal of Virology, vol. 79, no. 15, pp. 9608–9617, 2005. View at Publisher · View at Google Scholar · View at PubMed
  85. N. Kadowaki, “The divergence and interplay between pDC and mDC in humans,” Frontiers in Bioscience, vol. 14, no. 3, pp. 808–817, 2009. View at Publisher · View at Google Scholar
  86. F. Moschella, E. Proietti, I. Capone, and F. Belardelli, “Combination strategies for enhancing the efficacy of immunotherapy in cancer patients,” Annals of the New York Academy of Sciences, vol. 1194, pp. 169–178, 2010. View at Publisher · View at Google Scholar · View at PubMed
  87. M. S. Ola, M. Nawaz, and H. Ahsan, “Role of Bcl-2 family proteins and caspases in the regulation of apoptosis,” Molecular and Cellular Biochemistry, vol. 351, no. 1-2, pp. 41–58, 2011. View at Publisher · View at Google Scholar · View at PubMed
  88. P. J. Murray, “Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response,” Current Opinion in Pharmacology, vol. 6, no. 4, pp. 379–386, 2006. View at Publisher · View at Google Scholar · View at PubMed
  89. F. Cheng, H. W. Wang, A. Cuenca et al., “A critical role for Stat3 signaling in immune tolerance,” Immunity, vol. 19, no. 3, pp. 425–436, 2003. View at Publisher · View at Google Scholar
  90. Y. Nefedova, P. Cheng, D. Gilkes et al., “Activation of dendritic cells via inhibition of Jak2/STAT3 signaling,” Journal of Immunology, vol. 175, no. 7, pp. 4338–4346, 2005. View at Google Scholar
  91. N. Sánchez-Sánchez, L. Riol-Blanco, and J. L. Rodríguez-Fernández, “The multiple personalities of the chemokine receptor CCR7 in dendritic cells,” Journal of Immunology, vol. 176, no. 9, pp. 5153–5159, 2006. View at Google Scholar
  92. J. Alder, M. Hahn-Zoric, B. A. Andersson, and A. Karlsson-Parra, “Interferon-γ dose-dependently inhibits prostaglandin E2-mediated dendritic-cell-migration towards secondary lymphoid organ chemokines,” Vaccine, vol. 24, no. 49-50, pp. 7087–7094, 2006. View at Publisher · View at Google Scholar · View at PubMed
  93. U. Dianzani, A. Funaro, D. DiFranco et al., “Interaction between endothelium and CD4+CD45RA+ lymphocytes: role of the human CD38 molecule,” Journal of Immunology, vol. 153, no. 3, pp. 952–959, 1994. View at Google Scholar
  94. C. Pot, L. Apetoh, A. Awasthi, and V. K. Kuchroo, “Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells,” Journal of Interferon & Cytokine Research, vol. 30, no. 6, pp. 381–388, 2010. View at Google Scholar
  95. D. T. Denhardt, M. Noda, A. W. O'Regan, D. Pavlin, and J. S. Berman, “Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival,” Journal of Clinical Investigation, vol. 107, no. 9, pp. 1055–1061, 2001. View at Google Scholar
  96. G. Murugaiyan, A. Mittal, and H. L. Weiner, “Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis,” Journal of Immunology, vol. 181, no. 11, pp. 7480–7488, 2008. View at Google Scholar
  97. V. S. Ramgolam, Y. Sha, J. Jin, X. Zhang, and S. Markovic-Plese, “IFN-β inhibits human Th17 cell differentiation,” Journal of Immunology, vol. 183, no. 8, pp. 5418–5427, 2009. View at Publisher · View at Google Scholar · View at PubMed
  98. A. L. Mellor and D. H. Munn, “IDO expression by dendritic cells: tolerance and tryptophan catabolism,” Nature Reviews Immunology, vol. 4, no. 10, pp. 762–774, 2004. View at Publisher · View at Google Scholar · View at PubMed
  99. B. Jürgens, U. Hainz, D. Fuchs, T. Felzmann, and A. Heitger, “Interferon-γ-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells,” Blood, vol. 114, no. 15, pp. 3235–3243, 2009. View at Publisher · View at Google Scholar · View at PubMed
  100. M. J. Fenton, M. W. Vermeulen, S. Kim, M. Burdick, R. M. Strieter, and H. Kornfeld, “Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis,” Infection and Immunity, vol. 65, no. 12, pp. 5149–5156, 1997. View at Google Scholar
  101. D. Stober, R. Schirmbeck, and J. Reimann, “IL-12/IL-18-dependent IFN-γ release by murine dendritic cells,” Journal of Immunology, vol. 167, no. 2, pp. 957–965, 2001. View at Google Scholar
  102. D. M. Frucht, T. Fukao, C. Bogdan, H. Schindler, J. J. O'Shea, and S. Koyasu, “IFN-γ production by antigen-presenting cells: mechanisms emerge,” Trends in Immunology, vol. 22, no. 10, pp. 556–560, 2001. View at Publisher · View at Google Scholar
  103. K. Suzue, T. Asai, T. Takeuchi, and S. Koyasu, “In vivo role of IFN-γ produced by antigen-presenting cells in early host defense against intracellular pathogens,” European Journal of Immunology, vol. 33, no. 10, pp. 2666–2675, 2003. View at Publisher · View at Google Scholar · View at PubMed
  104. G. Lugo-Villarino, R. Maldonado-López, R. Possemato, C. Peñaranda, and L. H. Glimcher, “T-bet is required for optimal production of IFN-γ and antigen-specific T cell activation by dendritic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 13, pp. 7749–7754, 2003. View at Publisher · View at Google Scholar · View at PubMed
  105. A. A. Lighvani, D. M. Frucht, D. Jankovic et al., “T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 26, pp. 15137–15142, 2001. View at Publisher · View at Google Scholar · View at PubMed
  106. I. Fricke, D. Mitchell, J. Mittelstädt et al., “Mycobacteria induce IFN-γ production in human dendritic cells via triggering of TLR2,” Journal of Immunology, vol. 176, no. 9, pp. 5173–5182, 2006. View at Google Scholar
  107. Y. Iwai, H. Hemmi, O. Mizenina, S. Kuroda, K. Suda, and R. M. Steinman, “An IFN-γ-IL-18 signaling loop accelerates memory CD8+ T cell proliferation,” PLoS ONE, vol. 3, no. 6, Article ID e2404, 2008. View at Publisher · View at Google Scholar · View at PubMed
  108. H. Li, W. Wojciechowski, C. Dell'Agnola, N. E. Lopez, and I. Espinoza-Delgado, “IFN-γ and T-bet expression in human dendritic cells from normal donors and cancer patients is controlled through mechanisms involving ERK-1/2-dependent and IL-12-independent pathways,” Journal of Immunology, vol. 177, no. 6, pp. 3554–3563, 2006. View at Google Scholar
  109. E. M. Coccia, M. Severa, E. Giacomini et al., “Viral infection and toll-like receptor agonists induce a differential expression of type I and λ interferons in humans plasmacytoid and monocyte-derived dendritic cells,” European Journal of Immunology, vol. 34, no. 3, pp. 796–805, 2004. View at Publisher · View at Google Scholar · View at PubMed
  110. R. Trepiakas, A. E. Pedersen, Ö. Met, and I. M. Svane, “Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function,” Vaccine, vol. 27, no. 16, pp. 2213–2219, 2009. View at Publisher · View at Google Scholar · View at PubMed
  111. E. F. Castillo, S. W. Stonier, L. Frasca, and K. S. Schluns, “Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 trans-presentation,” Journal of Immunology, vol. 183, no. 8, pp. 4948–4956, 2009. View at Publisher · View at Google Scholar · View at PubMed
  112. S. W. Stonier, L. J. Ma, E. F. Castillo, and K. S. Schluns, “Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation,” Blood, vol. 112, no. 12, pp. 4546–4554, 2008. View at Publisher · View at Google Scholar · View at PubMed
  113. J. Borst, J. Hendriks, and Y. Xiao, “CD27 and CD70 in T cell and B cell activation,” Current Opinion in Immunology, vol. 17, no. 3, pp. 275–281, 2005. View at Publisher · View at Google Scholar · View at PubMed
  114. T. E. Boursalian, J. A. McEarchern, C. L. Law, and I. S. Grewal, “Targeting CD70 for human therapeutic use,” Advances in Experimental Medicine and Biology, vol. 647, pp. 108–119, 2009. View at Google Scholar
  115. A. D. Salama, T. Chitnis, J. Imitola et al., “Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis,” Journal of Experimental Medicine, vol. 198, no. 1, pp. 71–78, 2003. View at Publisher · View at Google Scholar · View at PubMed
  116. H. Yoshida and M. Yoshiyuki, “Regulation of immune responses by interleukin-27,” Immunological Reviews, vol. 226, no. 1, pp. 234–247, 2008. View at Publisher · View at Google Scholar · View at PubMed
  117. R. P. Donnelly and S. V. Kotenko, “Interferon-lambda: a new addition to an old family,” Journal of Interferon and Cytokine Research, vol. 30, no. 8, pp. 555–564, 2010. View at Publisher · View at Google Scholar · View at PubMed
  118. S. V. Kotenko, G. Gallagher, V. V. Baurin et al., “IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex,” Nature Immunology, vol. 4, no. 1, pp. 69–77, 2003. View at Publisher · View at Google Scholar · View at PubMed
  119. F. J. D. Mennechet and G. Uzé, “Interferon-λ-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells,” Blood, vol. 107, no. 11, pp. 4417–4423, 2006. View at Publisher · View at Google Scholar · View at PubMed
  120. J. Sirén, J. Pirhonen, I. Julkunen, and S. Matikainen, “IFN-α regulates TLR-dependent gene expression of IFN-α, IFN-β, IL-28, and IL-29,” Journal of Immunology, vol. 174, no. 4, pp. 1932–1937, 2005. View at Google Scholar
  121. K. B. Nguyen, L. P. Cousens, L. A. Doughty, G. C. Pien, J. E. Durbin, and C. A. Biron, “Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox,” Nature Immunology, vol. 1, no. 1, pp. 70–76, 2000. View at Google Scholar
  122. M. Rayamajhi, J. Humann, K. Penheiter, K. Andreasen, and L. L. Lenz, “Induction of IFN-αβ enables Listeria monocytogenes to suppress macrophage activation by IFN-γ,” Journal of Experimental Medicine, vol. 207, no. 2, pp. 327–337, 2010. View at Publisher · View at Google Scholar · View at PubMed
  123. M. Rayamajhi, J. Humann, S. Kearney, K. K. Hill, and L. L. Lenz, “Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections,” Virulence, vol. 1, no. 5, pp. 418–422, 2010. View at Publisher · View at Google Scholar · View at PubMed
  124. S. A. Stanley, J. E. Johndrow, P. Manzanillo, and J. S. Cox, “The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis,” Journal of Immunology, vol. 178, no. 5, pp. 3143–3152, 2007. View at Google Scholar
  125. H. Qiu, Y. Fan, A. G. Joyee et al., “Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages,” Journal of Immunology, vol. 181, no. 3, pp. 2092–2102, 2008. View at Google Scholar
  126. F. J. Martin, M. I. Gomez, D. M. Wetzel et al., “Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A,” Journal of Clinical Investigation, vol. 119, no. 7, pp. 1931–1939, 2009. View at Google Scholar
  127. A. Shahangian, E. K. Chow, X. Tian et al., “Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice,” Journal of Clinical Investigation, vol. 119, no. 7, pp. 1910–1920, 2009. View at Publisher · View at Google Scholar · View at PubMed
  128. E. Z. Kincaid and J. D. Ernst, “Mycobacterium tuberculosis exerts gene-selective inhibition of transcriptional responses to IFN-γ without inhibiting STAT1 function,” Journal of Immunology, vol. 171, no. 4, pp. 2042–2049, 2003. View at Google Scholar
  129. N. Meissner, S. Swain, K. McInnerney, S. Han, and A. G. Harmsen, “Type-I IFN signaling suppresses an excessive IFN-γ response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice,” American Journal of Pathology, vol. 176, no. 6, pp. 2806–2818, 2010. View at Publisher · View at Google Scholar · View at PubMed
  130. T. Hanada, H. Yoshida, S. Kato et al., “Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity,” Immunity, vol. 19, no. 3, pp. 437–450, 2003. View at Publisher · View at Google Scholar
  131. L. Moretta, G. Ferlazzo, C. Bottino et al., “Effector and regulatory events during natural killer-dendritic cell interactions,” Immunological Reviews, vol. 214, no. 1, pp. 219–228, 2006. View at Publisher · View at Google Scholar · View at PubMed